Health productsUpdated Mar 3, 2026Lentocilin S 1200Official source

    Health product recall in Canada: Lentocilin S 1200

    Share:

    In plain language

    This recall involves Lentocilin S 1200, an antibiotic imported into Canada. It is being imported due to a shortage of a similar Canadian-authorized drug. Healthcare professionals should be aware of differences in formulation and packaging compared to the Canadian product.

    What to do

    • Healthcare professionals should review the product information carefully.
    • Be aware of differences in formulation, dosage, and reconstitution requirements.
    • Monitor patients for potential adverse effects.
    • Note that this product contains soy phospholipids, which may cause reactions in some patients.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Lentocilin S 1200

      Model: 9908301

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the model number

      Model numbers are typically on the product label or packaging.

      Affected models: 9908301

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    This recall involves Lentocilin S 1200, an antibiotic imported into Canada. It is being imported due to a shortage of a similar Canadian-authorized drug. Healthcare professionals should be aware of differences in formulation and packaging compared to the Canadian product.

    What should consumers do?

    Healthcare professionals should review the product information carefully. Be aware of differences in formulation, dosage, and reconstitution requirements. Monitor patients for potential adverse effects. Note that this product contains soy phospholipids, which may cause reactions in some patients.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.

    When was this product recalled?

    This product was recalled on March 3, 2026.

    Is the Lentocilin S 1200 brand affected by this recall?

    Yes, Lentocilin S 1200 products are affected by this recall. This recall involves Lentocilin S 1200, an antibiotic imported into Canada. It is being imported due to a shortage of a similar Canadian-authorized drug. Healthcare professionals should be aware of differences in formulation and packaging compared to the Canadian product.